Market Value1,449,667,032
Total Holdings35
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
MQ / Marqeta, Inc.
PCVX / Vaxcyte, Inc.
ASML / ASML Holding N.V. - Depositary Receipt (Common Stock)
TSM / Taiwan Semiconductor Manufacturing Company Limited - Depositary Receipt (Common Stock)
INSP / Inspire Medical Systems, Inc.
INSM / Insmed Incorporated
LNZA / LanzaTech Global, Inc.
EPC / Edgewell Personal Care Company
BPMC / Blueprint Medicines Corporation
CRNX / Crinetics Pharmaceuticals, Inc.
ABCL / AbCellera Biologics Inc.
RLYB / Rallybio Corporation
LVTX / LAVA Therapeutics N.V.
MIRM / Mirum Pharmaceuticals, Inc.
BABA / Alibaba Group Holding Limited - Depositary Receipt (Common Stock)
TMCI / Treace Medical Concepts, Inc.
SPRB / Spruce Biosciences, Inc.
AAPL / Apple Inc.
RCKT / Rocket Pharmaceuticals, Inc.
CORT / Corcept Therapeutics Incorporated
CBAY / CymaBay Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
BN / Brookfield Corporation
KYTX / Kyverna Therapeutics, Inc.
CABO / Cable One, Inc.
EWTX / Edgewise Therapeutics, Inc.
BAM / Brookfield Asset Management Ltd.
BMRN / BioMarin Pharmaceutical Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
CRGX / CARGO Therapeutics, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
AVBP / ArriVent BioPharma, Inc.
LXEO / Lexeo Therapeutics, Inc.
PHVS / Pharvaris N.V.
CRM / Salesforce, Inc.
VERV / Verve Therapeutics, Inc.
SPRO / Spero Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
IOBT / IO Biotech, Inc.
GLTO / Galecto, Inc.
MGX / Metagenomi, Inc.